v3 Template
V

Valeo Pharma Inc.

Healthcare / Pharmaceutical Montreal, Canada ~20 employees
Founded
--
Employees (Est.)
~20
2 leaders known
Total Funding
$4.8M
Funding Rounds
1
Last Funding
2024-09-03

About Valeo Pharma Inc.

Valeo Pharma is a specialty pharmaceutical company committed to providing healthcare professionals and patients with innovative therapeutic solutions to improve quality of life. Rooted in specialty pharma, Valeo is focused on growing Canadian healthcare by licensing and acquiring Canadian rights to commercial stage, innovative, and proprietary drugs.

Products & Services

Respiratory/Allergy:Products focused on respiratory and allergy treatments.
Ophthalmology:Products targeting eye health and related conditions.
Specialty Products:Specialized therapeutic products for specific medical needs.
Neurology:Products addressing neurodegenerative diseases.
Oncology:Products for cancer treatment and management.

Specialties

Respiratory/Allergy Ophthalmology Specialty Products Neurology Oncology

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Debt
T: -
FT: Debt 		A: 4800000
MR: -
FA: US$4,800,000
FAN: 4800000 		D: 2024-09-03
FD: 2024-09-03 		1 investors
Debt Latest
2024-09-03
$4.8M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

S

Steve Saviuk

CEO

R

Richard Lajoie

Board Member

Recent News

Valeo Pharma Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare / Pharmaceutical
Company Size
~20 employees (est.)
Locations
Montreal, Canada

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro